APA (7th ed.) Citation

Glöckner, A., Schönland, S., Einsele, H., & Kröger, N. Rationale and design of the multicenter, national, randomized, open labeled phase III trial: Allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study). BMC.

Chicago Style (17th ed.) Citation

Glöckner, Annemarie, Stefan Schönland, Hermann Einsele, and Nicolaus Kröger. Rationale and Design of the Multicenter, National, Randomized, Open Labeled Phase III Trial: Allogeneic Stem Cell Transplantation as a Potential Curative Treatment for Patients with Relapsed or Progressed Multiple Myeloma (AlloRelapseMM Study). BMC.

MLA (9th ed.) Citation

Glöckner, Annemarie, et al. Rationale and Design of the Multicenter, National, Randomized, Open Labeled Phase III Trial: Allogeneic Stem Cell Transplantation as a Potential Curative Treatment for Patients with Relapsed or Progressed Multiple Myeloma (AlloRelapseMM Study). BMC.